Female Viagra may be on the way from drug company BioSante
By Peter SmithFebruary 14th, 2011, 9:00 pmComments (2)
According to pharmaceutical company BioSante, their not-yet-approved female-libido drug LibiGel doesn't cause cancer or heart attacks. This apparently has been a matter of some dispute, not with specific regard to LibiGel, but to hormone-treatment medications in general; in the past decade, the FDA has rejected on safety grounds several applications for testosterone creams, patches, and ointments said to boost female libido. (Testosterone injections also apparently reduce empathy. Wins all around here.)
Obviously there're massive profits in store for whichever drug company develops an at least semi-effective "female Viagra" that doesn't cause too much cancer, cardiovascular disaster, or vaginal inversion. This one may hit the market as soon as next year, assuming tests continue to be favorable. Whether female-libido drugs are really necessary remains, of course, an open question.
Commentarium (2 Comments)
Watching a really romantic movie/porn depending what you're into can most likelt work as well with no increased risk of cancer...
I have been using a topical testosterone gel called "AndroGel" for almost 3-4 years, the package specifically warns that after I apply it (to stomach and lower chest) to be careful NOT to make physical contact with a female for approx. 1 hour, til medication has been fully absorbed and dried, said can cause birth defects if she gets pregnant but can also cause side effects like facial hair (on her) etc., so a topical testosterone has been available with an RX for years prescribed for men, so now they spend billions getting the same thing approved for women? Now they put it in a pink plastic dispenser rather than the blue/gray one I get. What a crock of BS.
Now you say something